Countach Medical Corp — SEC Form D Filing

Countach Medical Corp filed an SEC Form D on June 5, 2026, reporting $400K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 5, 2026
Amount reported
$400K
Round stage
Seed
Industry
Medical Devices

What the company does

Securities: Equity. Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Countach Medical addresses the challenges associated with treating pararenal aneurysms through innovative medical devices.

Solution

The company develops novel, physician-assembled endografts to facilitate complex aortic repairs.

Verdict

Investors said yes at this moment because Countach Medical presented a focused approach to a niche medical issue, not due to a broadly validated market need. They were implicitly betting on the potential for disruptive innovation in a specialized area of medical devices, recognizing that early investment could lead to high returns if the technology gains traction. However, the limited upside arises from the lack of clarity around their buyer and replacements, revealing vulnerabilities in market durability and adoption.

Source: SEC EDGAR Form D filing